|
Chen, T C; Holick, M F (2000) Hexafluoro-1,25-dihydroxyvitamin D3 has markedly increased potency in inhibiting proliferation of cultured human keratinocytes compared with 1,25-dihydroxyvitamin D3. Br J Dermatol 143:72-8
|
|
Chen, T C; Persons, K S; Lu, Z et al. (2000) An evaluation of the biologic activity and vitamin D receptor binding affinity of the photoisomers of vitamin D3 and previtamin D3. J Nutr Biochem 11:267-72
|
|
Schilli, M B; Ray, S; Paus, R et al. (1997) Control of hair growth with parathyroid hormone (7-34). J Invest Dermatol 108:928-32
|
|
Holick, M F; Chen, M L; Kong, X F et al. (1996) Clinical uses for calciotropic hormones 1,25-dihydroxyvitamin D3 and parathyroid hormone-related peptide in dermatology: a new perspective. J Investig Dermatol Symp Proc 1:1-9
|
|
Chen, M L; Perez, A; Sanan, D K et al. (1996) Induction of vitamin D receptor mRNA expression in psoriatic plaques correlates with clinical response to 1,25-dihydroxyvitamin D3. J Invest Dermatol 106:637-41
|
|
Perez, A; Raab, R; Chen, T C et al. (1996) Safety and efficacy of oral calcitriol (1,25-dihydroxyvitamin D3) for the treatment of psoriasis. Br J Dermatol 134:1070-8
|
|
Perez, A; Chen, T C; Turner, A et al. (1996) Efficacy and safety of topical calcitriol (1,25-dihydroxyvitamin d3) for the treatment of psoriasis. Br J Dermatol 134:238-46
|
|
Holick, M F (1995) Noncalcemic actions of 1,25-dihydroxyvitamin D3 and clinical applications. Bone 17:107S-111S
|
|
Ray, S; Ray, R; Holick, M F (1995) Metabolism of 3H-1 alpha,25-dihydroxyvitamin D3 in cultured human keratinocytes. J Cell Biochem 59:117-22
|
|
Perez, A; Chen, T C; Turner, A et al. (1995) Pilot study of topical calcitriol (1,25-dihydroxyvitamin D3) for treating psoriasis in children. Arch Dermatol 131:961-2
|
Showing the most recent 10 out of 20 publications
